SugarBug (1.x)

K250264

Bench7, Inc. · cleared 2025-11-07 · product code MYN · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.5)
SugarBug is a software as a medical device (SaMD) that uses machine learning to label features that the reader should examine for evidence of decay.
Algorithmconvolutional neural network for semantic segmentation
source quote (p.5)
SugarBug uses convolutional neural network to perform a semantic segmentation task. The algorithm goes through every pixel in an image and assigns a probability value to it for the possibility that it contains decay. A threshold is used to determine which pixels are labeled in the device's output.
Adaptive (vs locked)No
source quote (p.5)
The software reads the selected image using local processing; images are not imported or sent to a cloud server any time during routine use.
PCCPFDA source did not state this
Cybersecurity addressedFDA source did not state this

Validation studies (2)

Standalone

n=400 images

Reader study (MRMC)

n=300 images

endpoints: The primary objective was to determine whether SugarBug improves diagnostic performance, as measured by weighted Alternative Free-response Receiver Operating Characteristic (wAFROC) area under the curve (AUC).; Secondary objectives included evaluating reader changes in sensitivity, specificity, and annotation quality (DICE scores), as well as assessing standalone model performance of SugarBug.

Reported performance (8 observations)

sensitivity0.674CI 0.615, 0.728
source quote (p.8)
Aided readers' lesion-level mean sensitivity was 0.674 (0.615, 0.728) while that of unaided readers was 0.540 (0.445, 0.621).
aurocas written: “auc0.725CI 0.683, 0.767
source quote (p.8)
The mean unaided reader wAFROC-AUC was 0.659 (0.611,0.707) while the mean aided reader wAFROC-AUC was 0.725 (0.683, 0.767).
sensitivityas written: “Standalone lesion-level sensitivity0.686CI 0.655, 0.717
source quote (p.7)
SugarBug's lesion-level sensitivity and mean FPPI were 0.686 (0.655, 0.717) and 0.231 (0.111, 0.303), respectively.
diceas written: “Standalone DICE coefficient versus ground truth0.746CI 0.724, 0.768
source quote (p.7)
The DICE coefficient versus ground truth was 0.746 (0.724, 0.768).
aurocas written: “Unaided reader wAFROC-AUC0.659CI 0.611,0.707
source quote (p.8)
The mean unaided reader wAFROC-AUC was 0.659 (0.611,0.707) while the mean aided reader wAFROC-AUC was 0.725 (0.683, 0.767).
sensitivityas written: “Unaided readers' lesion-level mean sensitivity0.54CI 0.445, 0.621
source quote (p.8)
Aided readers' lesion-level mean sensitivity was 0.674 (0.615, 0.728) while that of unaided readers was 0.540 (0.445, 0.621).
diceas written: “Unaided readings Mean DICE scores (lesion annotation similarity relative to ground truth)0.695CI 0.688, 0.702
source quote (p.8)
Mean DICE scores (lesion annotation similarity relative to ground truth) were 0.695 (0.688, 0.702) for unaided readings and 0.740 (0.733, 0.747) for aided readings, resulting in a mean difference of 0.045 (0.035,0.055).
diceas written: “Aided readings Mean DICE scores (lesion annotation similarity relative to ground truth)0.74CI 0.733, 0.747
source quote (p.8)
Mean DICE scores (lesion annotation similarity relative to ground truth) were 0.695 (0.688, 0.702) for unaided readings and 0.740 (0.733, 0.747) for aided readings, resulting in a mean difference of 0.045 (0.035,0.055).

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
0
MAUDE reports in code, 12mo
-100%
vs code's own 3-yr baseline
0
drift signals on this device

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K250264